Claudin 5 Across the Vascular Landscape: From Blood–Tissue Barrier Regulation to Disease Mechanisms
Cells · 29.08.2025 · 14 (17) · 1346
DOI: 10.3390/cells14171346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 29.08.2025. Verfasst von Mohamed S Selim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: Claudin-5, Blood-Brain Barrier. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NEI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Claudin 5 (Cldn5) is a critical tight junction protein essential for maintaining paracellular barrier integrity across endothelial and epithelial cells in barrier-forming tissues, including the blood–brain barrier and blood–retinal barrier. Cldn5 plays a central role in regulating vascular permeability, immune responses, and tissue homeostasis. The complex distribution and organ-specific regulation of Cldn5 underscore its potential as a promising therapeutic target. This review comprehensively analyzes the role of Cldn5 in endothelial and epithelial barrier function, its regulation of vascular permeability, and the discrepancies in the literature regarding its expression, regulation, and function in both physiological and pathological conditions across multiple organ systems, including the retina, brain, lung, heart, gut, kidney, liver, skin, and peripheral nerves, while emphasizing its tissue-specific expression patterns. We discuss how both reduced and excessive expressions of Cldn5 can disrupt barrier integrity and contribute to the pathogenesis of ischemic retinopathies, neuroinflammation, cardiovascular injury, and other forms of barrier dysfunction. Furthermore, we explore the dual role of Cldn5 as both a biomarker and a therapeutic target, highlighting emerging strategies such as RNA silencing, pharmacological stabilizers, and transcriptional modulators in controlling barrier leakage in disease conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Augusta, GA 30912, USA.
- Department of Research, Veterans Affairs Augusta Health Care System, Augusta, GA 30912, USA.
- Vascular Biology Center, Augusta University, Augusta, GA 30912, USA.
ORCID-Profile: Mohamed S Selim, Bayan R Matani, Harry O Henry-Ojo, S Priya Narayanan, Payaningal R Somanath
Förderung
- BLRD VA
- NEI NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Selim, M. S., Matani, B. R., Henry-Ojo, H. O., Narayanan, S. P., & Somanath, P. R. (2025). Claudin 5 Across the Vascular Landscape: From Blood–Tissue Barrier Regulation to Disease Mechanisms. Cells, 14(17), 1346. https://doi.org/10.3390/cells14171346
Vancouver
Selim MS, Matani BR, Henry-Ojo HO, Narayanan SP, Somanath PR. Claudin 5 Across the Vascular Landscape: From Blood–Tissue Barrier Regulation to Disease Mechanisms. Cells. 2025;14(17):1346. doi:10.3390/cells14171346
BibTeX
@article{Selim2025,
author = {Selim, Mohamed S and Matani, Bayan R and Henry-Ojo, Harry O and Narayanan, S Priya and Somanath, Payaningal R},
title = {Claudin 5 Across the Vascular Landscape: From Blood–Tissue Barrier Regulation to Disease Mechanisms},
journal = {Cells},
year = {2025},
volume = {14},
number = {17},
pages = {1346},
doi = {10.3390/cells14171346}
}
EUVIMED